Regeneron Vows ‘Vigorous’ Defense Against Allegations It Paid Kickbacks For Eye Drug

The U.S. district attorney for Massachusetts filed suit against the drugmaker last week, alleging that it paid tens of millions in kickbacks through a copay foundation for Eylea, a drug used to treat macular degeneration.

Leave a Reply

Your email address will not be published. Required fields are marked *